A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity

BACKGROUND: Tacrolimus is a widely used calcineurin inhibitor in kidney transplantation. It is available as twice-daily Prograf® (Tac-BID) and once-daily Advagraf® (Tac-OD). Although therapeutically equivalent, some patients require dose adjustments to achieve similar trough concentrations [C(0)] af...

Descripción completa

Detalles Bibliográficos
Autores principales: Glick, Lauren, Shamy, Fernanda, Nash, Michelle, Sokwala, Ahmed, Malavade, Tushar, Prasad, GV Ramesh, Zaltzman, Jeffrey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995788/
https://www.ncbi.nlm.nih.gov/pubmed/24606676
http://dx.doi.org/10.1186/2047-1440-3-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995788/
https://www.ncbi.nlm.nih.gov/pubmed/24606676
http://dx.doi.org/10.1186/2047-1440-3-7

Ejemplares similares